Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Astrazeneca (AZN) Share News

LONDON MARKET PRE-OPEN: Inmarsat Accepts GBP3.4 Billion Takeover Offer

25th Mar 2019 07:45

LONDON (Alliance News) - Stock prices in London are seen opening in the red on Monday, tracking Asian equity markets lower following heavy losses in the US on Friday, amid fears of an impending US Read More

AstraZeneca Drug Farxiga Shows Promise In Diabetic Patients

18th Mar 2019 14:27

LONDON (Alliance News) - AstraZeneca PLC on Monday said the first sub-analyses from its phase three trial of Farxiga found it reduced the relative risk of major adverse cardiovascular events in a Read More

LONDON MARKET PRE-OPEN: FIS To Buy Worldpay At USD43 Billion Value

18th Mar 2019 07:46

LONDON (Alliance News) - Stock prices in London are seen opening in the green on Monday following strong gains in Asian equity markets overnight, amid hopes that a trade resolution between the US Read More

TI Fluid Systems Hires Ex-AstraZeneca HR Boss Dunstan As Non-Executive

8th Mar 2019 08:19

LONDON (Alliance News) - TI Fluid Systems PLC said Friday it hired former AstraZeneca PLC and Wincanton PLC executive Andrea Dunstan as a non-executive director at the liquid handling systems with Read More

EU Committee Recommends AstraZeneca Drug Lynparza In Breast Cancer

1st Mar 2019 14:49

LONDON (Alliance News) - AstraZeneca PLC on Friday said a committee of the European Medicines Agency has recommended cancer drug Lynparza for use in incurable breast cancer patients.The for Read More

TOP NEWS: AstraZeneca Cancer Drug Lynparza In Clinical Trial Success

26th Feb 2019 08:52

LONDON (Alliance News) - FTSE 100-listed drugmaker AstraZeneca PLC and its partner Merck & Co Inc said Tuesday its potentially blockbuster Lynparza cancer treatment had met the primary of one Read More

WINNERS & LOSERS SUMMARY: Centamin Sinks As Lower Output Hurts Profit

25th Feb 2019 10:45

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------British up Read More

TOP NEWS: AstraZeneca Brilinta Drug Trial Reaches Primary End Point

25th Feb 2019 08:38

LONDON (Alliance News) - FTSE 100-listed drugmaker AstraZeneca PLC said Monday its late phase clinical trial for its blockbuster Brilinta cardiovascular drug had met its primary Phase III THEMIS - Read More

LONDON MARKET CLOSE: Micro Focus And AstraZeneca Drive FTSE 100 Higher

14th Feb 2019 17:23

LONDON (Alliance News) - Stocks in London ended mixed on Thursday, with the FTSE 100 touching a fresh four-month high after strong gains from Micro Focus International and and in Read More

LONDON MARKET MIDDAY: Micro Focus, AstraZeneca Help Extend FTSE Rally

14th Feb 2019 12:13

LONDON (Alliance News) - The FTSE 100 was posting its fourth consecutive session of gains on Thursday at midday as an overall improvement in market mood due to hopes for US-China trade talks got a Read More

EXTRA: Cancer Drug Tagrisso Set To Be AstraZeneca's 2019 Best Seller

14th Feb 2019 11:25

LONDON (Alliance News) - AstraZeneca PLC on Thursday posted particularly strong annual sales growth from its Oncology segment, with lung cancer drug Tagrisso set to become its biggest seller in in Read More

WINNERS & LOSERS SUMMARY: ConvaTec Slumps On "Disappointing" Results

14th Feb 2019 11:17

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------Micro up Read More

LONDON MARKET OPEN: Micro Focus, AstraZeneca Keep FTSE In Rally Mode

14th Feb 2019 08:36

LONDON (Alliance News) - The FTSE 100 was sustaining its recent winning streak in early trade on Thursday, boosted by well-received annual results from Micro Focus International a Read More

TOP NEWS: AstraZeneca Profit Falls, Guides To Earnings Growth In 2019

14th Feb 2019 07:46

LONDON (Alliance News) - AstraZeneca PLC on Thursday posted a drop in annual profit after getting a boost from its Lynparza cancer drug collaboration the year before, though guided to earnings for Read More

LONDON MARKET PRE-OPEN: Lower Call; Restaurant Group CEO To Depart

14th Feb 2019 07:46

LONDON (Alliance News) - London share prices are set to pull back slightly on Thursday following three consecutive sessions of gains which had been driven by hopes of a trade detente between the a Read More

UK Earnings, Trading Statements Calendar - Next 7 Days

7th Feb 2019 16:07

Friday 8 February SSETrading Statement ShaftesburyTrading 11 MiningFull 12 Read More

TOP NEWS: AstraZeneca's Fasenra Gets US FDA Orphan Drug Designation

6th Feb 2019 07:57

LONDON (Alliance News) - AstraZeneca PLC on Wednesday said the US Food & Drug Administration has granted Orphan Drug Designation to Fasenra for the treatment of hypereosinophilic is first drug Read More

LONDON MARKET PRE-OPEN: Barratt Profit Up; Interserve Gets Debt Deal

6th Feb 2019 07:46

LONDON (Alliance News) - Stock prices in London on Wednesday are set to pull back from Tuesday's rally, while the pound remained below the USD1.30 mark after disappointing UK data released in Read More

BROKER RATINGS SUMMARY: Citigroup And Goldman Downgrade Property Firms

25th Jan 2019 09:47

LONDON (Alliance News) - The following London-listed shares received analyst recommendations Friday morning and late Thursday:----------FTSE 100----------GOLDMAN RAISES TO - TO Read More

Circassia Pharma To Acquire Full US Tudorza Rights From AstraZeneca

11th Dec 2018 13:15

LONDON (Alliance News) - Circassia Pharmaceuticals PLC said Tuesday it plans to exercise its option to acquire the full US rights to the Tudorza chronic obstructive pulmonary disease drug from to Read More

FTSE 100 Latest

Value9,517.30

Change-10.35